menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Engineered...
source image

Bioengineer

2d

read

111

img
dot

Image Credit: Bioengineer

Engineered Base Editors Correct Mitochondrial Disease in Rats

  • Researchers have engineered mitochondrial DNA base editors that can generate and correct mutations within living rat models, marking a significant advancement in understanding and treating mitochondrial diseases.
  • The study introduced an adenine base editor tailored for mitochondrial genomes, which was able to efficiently model Leigh syndrome in rats with high activity and fidelity.
  • A dual-editor approach involving adenine and cytosine base editors enabled the correction of pathogenic mutations in rat embryos, showing promise for potential gene therapies targeting mitochondrial diseases.
  • This breakthrough allows for precise point mutations in mitochondrial DNA without the need for traditional gene editing mechanisms, offering a new avenue for disease modeling and intervention.
  • By editing mitochondrial genomes early in development, systemic distribution of corrected mitochondria was achieved, enhancing the modeling and therapeutic effects in the rat models of Leigh syndrome.
  • The success of this research paves the way for broader applications in correcting inherited mitochondrial mutations, potentially revolutionizing personalized medicine and genetic disease treatments.
  • The engineered base editors address challenges related to mitochondrial heteroplasmy and provide a versatile toolkit for manipulating all four DNA bases within the mitochondrial genome, expanding possibilities for studying various mitochondrial pathologies.
  • The study's innovative use of base editing technology within mitochondria challenges conventional beliefs about the accessibility of mitochondrial DNA for precise genome editing and opens new avenues for research in mitochondrial biology and therapeutics.
  • While acknowledging the need to improve editing uniformity and safety in future studies, the researchers highlight the transformative potential of this technology in advancing mitochondrial genetics and clinical therapeutics.
  • In conclusion, the engineered mitochondrial base editors offer a groundbreaking approach to modeling and correcting mitochondrial mutations, presenting a significant step forward in mitochondrial medicine with far-reaching implications for genetic disease treatment.

Read Full Article

like

6 Likes

For uninterrupted reading, download the app